索宝蛋白
(603231)
| 流通市值：17.63亿 | | | 总市值：31.76亿 |
| 流通股本：1.06亿 | | | 总股本：1.91亿 |
| 报告期 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 124,349,141.98 | 320,026,347.41 | 184,013,657.12 | 171,593,611.02 |
| 应收票据及应收账款 | 158,633,551.23 | 164,438,641.96 | 172,361,984.4 | 180,230,858.83 |
| 其中：应收票据 | 13,373,329.94 | 15,804,164.71 | 24,879,460 | 22,190,929.5 |
| 应收账款 | 145,260,221.29 | 148,634,477.25 | 147,482,524.4 | 158,039,929.33 |
| 应收款项融资 | 8,457,246.75 | 6,343,909.15 | 792,814.5 | 5,196,978.23 |
| 预付款项 | 96,812,936.06 | 13,137,272.72 | 13,909,846.91 | 16,880,365.58 |
| 其他应收款合计 | 13,803,117.09 | 7,293,726.03 | 4,788,917.13 | 12,072,596.14 |
| 存货 | 307,541,074.37 | 279,399,036.07 | 203,054,820.66 | 251,725,162.31 |
| 其他流动资产 | 8,400,416.64 | 6,055,607.51 | 4,636,853.26 | 3,715,967.21 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 1,328,511,118.23 | 1,296,925,659.65 | 1,297,508,540.44 | 1,302,184,367.59 |
| 非流动资产: | | | | |
| 长期股权投资 | 12,552,886.67 | 13,706,941.35 | 14,995,116.93 | 14,788,234.18 |
| 固定资产 | 597,621,917.72 | 612,221,966.53 | 582,347,441.59 | 583,126,288.86 |
| 在建工程 | 126,648,379.57 | 92,623,009.76 | 52,669,776.75 | 37,616,862.95 |
| 使用权资产 | 815,721.6 | 875,722.27 | 1,222,964.67 | 685,413.28 |
| 无形资产 | 61,150,100.91 | 61,688,556.38 | 61,783,601.28 | 62,383,485.51 |
| 递延所得税资产 | 4,058,637.18 | 3,959,467.23 | 3,381,619.08 | 3,440,448.6 |
| 其他非流动资产 | 6,135,332.1 | 2,648,590.77 | 18,239,792.7 | 6,555,427.26 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 808,982,975.75 | 787,724,254.29 | 734,640,313 | 708,596,160.64 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 2,137,494,093.98 | 2,084,649,913.94 | 2,032,148,853.44 | 2,010,780,528.23 |
| 流动负债: | | | | |
| 短期借款 | 23,774,000 | 23,774,000 | 23,774,000 | 23,774,000 |
| 交易性金融负债 | - | - | - | 466,312 |
| 应付票据及应付账款 | 134,919,375.67 | 120,217,223.77 | 98,638,386.14 | 96,945,943.5 |
| 应付账款 | 134,919,375.67 | 120,217,223.77 | 98,638,386.14 | 96,945,943.5 |
| 合同负债 | 6,486,110.27 | 5,571,860.32 | 9,827,296.64 | 8,380,883.85 |
| 应付职工薪酬 | 8,774,004.89 | 20,970,594.94 | 11,456,899.25 | 10,352,667.39 |
| 应交税费 | 15,004,104.71 | 9,072,972.7 | 6,206,418.45 | 7,155,740.85 |
| 其他应付款合计 | 2,859,563.63 | 2,792,883.33 | 3,073,425.25 | 2,297,520.15 |
| 一年内到期的非流动负债 | 494,106.13 | 714,395.98 | 932,293.54 | 267,883.7 |
| 其他流动负债 | 6,084,972.78 | 7,716,737.92 | 12,323,047.77 | 15,126,173.33 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 198,396,238.08 | 190,830,668.96 | 166,231,767.04 | 164,767,124.77 |
| 非流动负债: | | | | |
| 递延收益 | 13,716,367.47 | 12,627,595.79 | 13,881,177.05 | 14,102,758.31 |
| 递延所得税负债 | 6,483,301.91 | 6,773,448.11 | 7,110,000.88 | 7,867,260.3 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 20,199,669.38 | 19,401,043.9 | 20,991,177.93 | 21,970,018.61 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 218,595,907.46 | 210,231,712.86 | 187,222,944.97 | 186,737,143.38 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 191,459,105 | 191,459,105 | 191,459,105 | 191,459,105 |
| 资本公积 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 | 1,237,495,066.7 |
| 其他综合收益 | -4,017.03 | -7,910.06 | - | - |
| 盈余公积 | 43,366,961.84 | 43,366,961.84 | 37,140,735.62 | 37,140,735.62 |
| 未分配利润 | 446,581,070.01 | 402,104,977.6 | 378,831,001.15 | 357,948,477.53 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 1,918,898,186.52 | 1,874,418,201.08 | 1,844,925,908.47 | 1,824,043,384.85 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 1,918,898,186.52 | 1,874,418,201.08 | 1,844,925,908.47 | 1,824,043,384.85 |
| 负债和股东权益合计 | 2,137,494,093.98 | 2,084,649,913.94 | 2,032,148,853.44 | 2,010,780,528.23 |
| 公告日期 | 2025-04-25 | 2025-04-25 | 2024-10-26 | 2024-08-30 |
| 审计意见(境内) | | 标准无保留意见 | | |